Is Decongestion Discordant With HF Outcomes? Tolvaptan disappoints in TACTICS-HF, SECRET of CHF trials
ORLANDO — Fluid loss associated with adding tolvaptan (Samsca) to a standard regimen of furosemide did not translate into better clinical outcomes for heart failure patients, two studies suggested.